Masimo Corporation $MASI Shares Sold by Comerica Bank

Comerica Bank reduced its position in shares of Masimo Corporation (NASDAQ:MASI) by 94.8% during the fourth quarter, HoldingsChannel reports. The firm owned 12,233 shares of the medical equipment provider’s stock after selling 221,194 shares during the quarter. Comerica Bank’s holdings in Masimo were worth $1,591,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in the company. Vanguard Group Inc. lifted its position in shares of Masimo by 3.7% during the third quarter. Vanguard Group Inc. now owns 4,810,011 shares of the medical equipment provider’s stock worth $709,717,000 after purchasing an additional 171,876 shares in the last quarter. Massachusetts Financial Services Co. MA lifted its position in shares of Masimo by 1.7% during the fourth quarter. Massachusetts Financial Services Co. MA now owns 2,663,875 shares of the medical equipment provider’s stock worth $346,464,000 after purchasing an additional 43,915 shares in the last quarter. State Street Corp lifted its position in shares of Masimo by 0.7% during the second quarter. State Street Corp now owns 1,486,394 shares of the medical equipment provider’s stock worth $250,041,000 after purchasing an additional 10,403 shares in the last quarter. Westfield Capital Management Co. LP lifted its position in shares of Masimo by 20.2% during the third quarter. Westfield Capital Management Co. LP now owns 1,419,250 shares of the medical equipment provider’s stock worth $209,410,000 after purchasing an additional 238,047 shares in the last quarter. Finally, Alyeska Investment Group L.P. lifted its position in shares of Masimo by 21.7% during the third quarter. Alyeska Investment Group L.P. now owns 1,381,085 shares of the medical equipment provider’s stock worth $203,779,000 after purchasing an additional 246,595 shares in the last quarter. 85.96% of the stock is owned by institutional investors and hedge funds.

Masimo Stock Performance

Shares of MASI opened at $178.50 on Friday. The firm has a 50-day moving average price of $177.41 and a 200 day moving average price of $154.63. The firm has a market capitalization of $9.35 billion, a PE ratio of -16.94, a P/E/G ratio of 1.81 and a beta of 1.13. The company has a quick ratio of 1.47, a current ratio of 2.68 and a debt-to-equity ratio of 0.56. Masimo Corporation has a 52-week low of $125.94 and a 52-week high of $179.00.

Analyst Upgrades and Downgrades

A number of research firms have commented on MASI. Raymond James Financial downgraded shares of Masimo from an “outperform” rating to a “market perform” rating in a research note on Friday, March 27th. Wells Fargo & Company upgraded shares of Masimo to a “hold” rating in a research note on Wednesday, March 18th. BTIG Research downgraded shares of Masimo from a “buy” rating to a “neutral” rating in a research note on Wednesday, February 18th. Wolfe Research downgraded shares of Masimo from a “strong-buy” rating to a “hold” rating in a research note on Thursday, February 19th. Finally, Weiss Ratings upgraded shares of Masimo from a “sell (d-)” rating to a “hold (c-)” rating in a research note on Wednesday. Nine analysts have rated the stock with a Hold rating, According to data from MarketBeat, Masimo presently has a consensus rating of “Hold” and an average target price of $180.40.

Masimo Company Profile

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.